These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

357 related items for PubMed ID: 38869039

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Direct Assessment of Plasma/Serum Sample Quality for Proteomics Biomarker Investigation.
    Greco V, Piras C, Pieroni L, Urbani A.
    Methods Mol Biol; 2017; 1619():3-21. PubMed ID: 28674873
    [Abstract] [Full Text] [Related]

  • 23. SWATH-MS Protocols in Human Diseases.
    Chantada-Vázquez MDP, García Vence M, Serna A, Núñez C, Bravo SB.
    Methods Mol Biol; 2021; 2259():105-141. PubMed ID: 33687711
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Proteomic investigation on bio-corona of Au, Ag and Fe nanoparticles for the discovery of triple negative breast cancer serum protein biomarkers.
    Del Pilar Chantada-Vázquez M, López AC, Vence MG, Vázquez-Estévez S, Acea-Nebril B, Calatayud DG, Jardiel T, Bravo SB, Núñez C.
    J Proteomics; 2020 Feb 10; 212():103581. PubMed ID: 31731051
    [Abstract] [Full Text] [Related]

  • 26. Biomarker discovery in mass spectrometry-based urinary proteomics.
    Thomas S, Hao L, Ricke WA, Li L.
    Proteomics Clin Appl; 2016 Apr 10; 10(4):358-70. PubMed ID: 26703953
    [Abstract] [Full Text] [Related]

  • 27. Proteomics comparison of exosomes from serum and plasma between ultracentrifugation and polymer-based precipitation kit methods.
    Cao F, Gao Y, Chu Q, Wu Q, Zhao L, Lan T, Zhao L.
    Electrophoresis; 2019 Dec 10; 40(23-24):3092-3098. PubMed ID: 31621929
    [Abstract] [Full Text] [Related]

  • 28. Detailed analysis of the plasma extracellular vesicle proteome after separation from lipoproteins.
    Karimi N, Cvjetkovic A, Jang SC, Crescitelli R, Hosseinpour Feizi MA, Nieuwland R, Lötvall J, Lässer C.
    Cell Mol Life Sci; 2018 Aug 10; 75(15):2873-2886. PubMed ID: 29441425
    [Abstract] [Full Text] [Related]

  • 29. Mass spectrometry-based biomarker discovery: toward a global proteome index of individuality.
    Hawkridge AM, Muddiman DC.
    Annu Rev Anal Chem (Palo Alto Calif); 2009 Aug 10; 2():265-77. PubMed ID: 20636062
    [Abstract] [Full Text] [Related]

  • 30. Mass Spectrometry-Based Plasma Proteomics: Considerations from Sample Collection to Achieving Translational Data.
    Ignjatovic V, Geyer PE, Palaniappan KK, Chaaban JE, Omenn GS, Baker MS, Deutsch EW, Schwenk JM.
    J Proteome Res; 2019 Dec 06; 18(12):4085-4097. PubMed ID: 31573204
    [Abstract] [Full Text] [Related]

  • 31. Mass spectrometry based proteomics profiling as diagnostic tool in oncology: current status and future perspective.
    Findeisen P, Neumaier M.
    Clin Chem Lab Med; 2009 Dec 06; 47(6):666-84. PubMed ID: 19445650
    [Abstract] [Full Text] [Related]

  • 32. Rapid Plasma Proteome Profiling via Nanoparticle Protein Corona and Direct Infusion Mass Spectrometry.
    Jiang Y, Meyer JG.
    J Proteome Res; 2024 Aug 02; 23(8):3649-3658. PubMed ID: 39007500
    [Abstract] [Full Text] [Related]

  • 33. Mass spectrometry of extracellular vesicles.
    Pocsfalvi G, Stanly C, Vilasi A, Fiume I, Capasso G, Turiák L, Buzas EI, Vékey K.
    Mass Spectrom Rev; 2016 Aug 02; 35(1):3-21. PubMed ID: 25705034
    [Abstract] [Full Text] [Related]

  • 34. Protocol for Plasma Extracellular Vesicle and Particle Isolation and Mass Spectrometry-Based Proteomic Identification.
    Kenari AN, Bojmar L, Heissel S, Molina H, Lyden D, Hoshino A.
    Methods Mol Biol; 2023 Aug 02; 2628():291-300. PubMed ID: 36781793
    [Abstract] [Full Text] [Related]

  • 35. Blood biomarker discovery in drug-free schizophrenia: the contributionof proteomics and multiplex immunoassays.
    Sabherwal S, English JA, Föcking M, Cagney G, Cotter DR.
    Expert Rev Proteomics; 2016 Dec 02; 13(12):1141-1155. PubMed ID: 27771981
    [Abstract] [Full Text] [Related]

  • 36.
    Kobeissy FH, Wolahan SM, Hirt D, Glenn TC.
    ; 2015 Dec 02. PubMed ID: 26269925
    [Abstract] [Full Text] [Related]

  • 37. Proteomics approaches in the quest of kidney disease biomarkers.
    Frantzi M, Bitsika V, Charonis A, Vlahou A.
    Prilozi; 2011 Dec 02; 32(2):33-51. PubMed ID: 22286613
    [Abstract] [Full Text] [Related]

  • 38. Discovery of Candidate Biomarkers.
    Wiktorowicz JE, Soman KV.
    Adv Exp Med Biol; 2016 Dec 02; 919():443-462. PubMed ID: 27975230
    [Abstract] [Full Text] [Related]

  • 39. Best practice of identification and proteomic analysis of extracellular vesicles in human health and disease.
    Sódar BW, Kovács Á, Visnovitz T, Pállinger É, Vékey K, Pocsfalvi G, Turiák L, Buzás EI.
    Expert Rev Proteomics; 2017 Dec 02; 14(12):1073-1090. PubMed ID: 29025360
    [Abstract] [Full Text] [Related]

  • 40. Discovery of novel plasma protein biomarkers to predict imminent cystic fibrosis pulmonary exacerbations using multiple reaction monitoring mass spectrometry.
    Quon BS, Dai DL, Hollander Z, Ng RT, Tebbutt SJ, Man SF, Wilcox PG, Sin DD.
    Thorax; 2016 Mar 02; 71(3):216-22. PubMed ID: 25777587
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.